Abstract: Disclosed are an electrolyte membrane of a membrane-electrode assembly including an electronic insulation layer, which greatly improves the durability of the electrolyte membrane, and a method of preparing the same. The electrolyte membrane includes an ion exchange layer and an electronic insulation layer provided on the ion exchange layer, and the electronic insulation layer includes one or more catalyst complexes, and a second ionomer Particularly, each of the one or more catalyst complex includes a catalyst particle and a first ionomer coated on the entirety or a portion of the surface of the catalyst particle, and the one or more catalyst complexes are dispersed the second ionomer.

Abstract: An image encoding/decoding method, device and recording medium based on accumulation of a region of interest of the present disclosure may include partitioning a current image to acquire a region of interest, cumulatively expressing the region of interest in a reference image of the current image and decoding the current image based on a reference image in which the region of interest is cumulatively expressed.

Abstract: A vehicle configured for container-swapping, includes: a main frame including a pair of drive modules spaced in a forward/backward direction of the vehicle, and a connecting portion extending in the forward/backward direction of the vehicle to connect the pair of drive modules so that a coupling space is formed therebetween; a container module selectively inserted into the coupling space of the main frame; and a coupling portion configured to couple the main frame and the container to each other while the container module is inserted into the coupling space of the main frame, wherein a driving portion operates and moves the main frame so that the container module is inserted into the coupling space of the main frame.

Abstract: The present invention relates to an antigen-binding molecule comprising a heavy chain variable region comprising a heavy-chain complementarity-determining region 1 (HCDR1) comprising an amino acid sequence represented by Sequence No. 1, an HCDR2 comprising an amino acid sequence represented by Sequence No. 2, and an HCDR3 comprising an amino acid sequence represented by Sequence No. 3; a light-chain variable region comprising a light-chain complementarity-determining region 1 (LCDR1) comprising an amino acid sequence represented by Sequence No. 4, an LCDR2 comprising an amino acid sequence represented by Sequence No. 5, and an LCDR3 comprising an amino acid sequence represented by Sequence No. 6; wherein the antigen-binding molecule is a T cell receptor (TCR); and to a cell line expressing the same.

Abstract: A multilayer ceramic capacitor includes a body including a dielectric layer and first and second internal electrodes disposed with the dielectric layer interposed therebetween; first and second connection electrodes penetrating the body in a direction perpendicular to the dielectric layer and connected to the first internal electrode; third and fourth connection electrodes penetrating the body in a in a direction perpendicular to the dielectric layer and connected to the second internal electrode; first and second external electrodes disposed on both surfaces of the body, and connected to the first and second connection electrodes; and third and fourth external electrodes connected to the third and fourth connection electrodes, and at least a portion of the first and second connection electrodes is exposed to the surface of the body.

Abstract: The present invention provides a method for preventing or treating liver cancer in a subject comprising administrating at least one selected from the group consisting of an Ssu72 peptide, a polynucleotide encoding the Ssu72 peptide and an expression vector containing the polynucleotide to the subject.

Abstract: Disclosed herein is a method for image preprocessing based on an object of interest. The method includes extracting an object region of interest from an input image, adjusting the object of region of interest, and adjusting a background region excluding the object region of interest.

Abstract: The present invention relates to a heteroaryl derivative compound and a use thereof. Since the heteroaryl derivative of the present invention exhibits excellent inhibitory activity against EGFR, the heteroaryl derivative can be usefully used as a therapeutic agent for EGFR-associated diseases.

Abstract: A gravity type water-purifying device is provided.

Abstract: The present disclosure relates to a polyester copolymer having excellent strength and heat resistance, and a product comprising the same.

Abstract: The polyester copolymer according to the present disclosure can be extrusion-molded, and thus, can be usefully applied for the preparation of various containers.

Abstract: An example camera and a method for extracting depth information by the camera having a first lens and a second lens are provided. The method includes photographing, by the first lens, a first image; photographing, by the second lens, a second image of a same scene; down-sampling the first image to a resolution of the second image if the first image is an image having a higher resolution than a resolution of the second image; correcting the down-sampled first image to match the down-sampled first image to the second image; and extracting the depth information from the corrected down-sampled first image and the second image.

Abstract: An example camera and a method for extracting depth information by the camera having a first lens and a second lens are provided. The method includes photographing, by the first lens, a first image; photographing, by the second lens, a second image of a same scene; down-sampling the first image to a resolution of the second image if the first image is an image having a higher resolution than a resolution of the second image; correcting the down-sampled first image to match the down-sampled first image to the second image; and extracting the depth information from the corrected down-sampled first image and the second image.

Abstract: A camera and a method for extracting depth information by the camera having a first lens and a second lens are provided. The method includes photographing, by the first lens, a first image; photographing, by the second lens, a second image of a same scene; down-sampling the first image to a resolution of the second image if the first image is an image having a higher resolution than a resolution of the second image; correcting the down-sampled first image to match the down-sampled first image to the second image; and extracting the depth information from the corrected down-sampled first image and the second image.

Abstract: An electronic device is provided. The electronic device includes a housing, a first image sensor configured to provide a first angle of view, a second image sensor configured to provide a second angle of view, and a processor. The processor is configured to obtain a first image having first resolution for a plurality of objects outside the electronic device, the plurality of objects corresponding to the first angle of view, to obtain a second image having second resolution for some objects corresponding to the second angle of view among the plurality of objects, to crop a third image having the second resolution, corresponding to at least part of the some objects, from the second image based on at least a depth-map using the first image and the second image, and to compose the third image with a region corresponding to the at least part of the some objects in the first image.

Abstract: A Hunter syndrome therapeutic agent contains a first composition to be intravenously injected and a second composition to be subcutaneously injected. The agent can reduce the number of visits to the hospital by patients with Hunter syndrome to twice a month or less. It maintains a medicinal effect equivalent to or greater than that of a conventional once-a-week IV injection, increases drug-taking compliance of patients in comparison to conventional therapeutic agents and treatment methods, and enables enhanced patient welfare and convenience.

Abstract: A Hunter syndrome therapeutic agent contains a first composition to be intravenously injected and a second composition to be subcutaneously injected. The agent can reduce the number of visits to the hospital by patients with Hunter syndrome to twice a month or less. It maintains a medicinal effect equivalent to or greater than that of a conventional once-a-week IV injection, increases drug-taking compliance of patients in comparison to conventional therapeutic agents and treatment methods, and enables enhanced patient welfare and convenience.

Abstract: A method of recognizing motion of an object may include periodically obtaining depth data of a first resolution and two-dimensional data of a second resolution with respect to a scene using an image capturing device, wherein the second resolution is higher than the first resolution; determining a motion tracking region by recognizing a target object in the scene based on the depth data, such that the motion tracking region corresponds to a portion of a frame and the portion includes the target object; periodically obtaining tracking region data of the second resolution corresponding to the motion tracking region; and/or analyzing the motion of the target object based on the tracking region data.

Abstract: An image capture method performed by a depth sensor includes; emitting a first source signal having a first amplitude towards a scene, and thereafter emitting a second source signal having a second amplitude different from the first amplitude towards the scene, capturing a first image in response to the first source signal and capturing a second image in response to the second source signal, and interpolating the first and second images to generate a final image.

Abstract: A Hunter syndrome therapeutic agent contains a first composition to be intravenously injected and a second composition to be subcutaneously injected. The agent can reduce the number of visits to the hospital by patients with Hunter syndrome to twice a month or less. It maintains a medicinal effect equivalent to or greater than that of a conventional once-a-week IV injection, increases drug-taking compliance of patients in comparison to conventional therapeutic agents and treatment methods, and enables enhanced patient welfare and convenience.